Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Mar;7(3):377–380. doi: 10.1128/aac.7.3.377

Desferrioxamine B, an Inhibitor of Escherichia coli Motility, Reversing the Stimulating Effect of Cyclic Adenosine 3′,5′-Monophosphate

Hiromi B Maruyama 1, Haruyoshi Azuma 1, Yoshiaki Kotoh 1, Yasuji Suhara 1
PMCID: PMC429142  PMID: 166612

Abstract

A substance inhibiting Escherichia coli motility was isolated by “motilometry” assay from the culture broth of Streptomyces sp. strain NR9GG8 and was found to be identical with desferrioxamine B. Its inhibitory effect was reversed by cyclic adenosine 3′,5′-monophosphate (cAMP), while the motility stimulation by cAMP was diminished by this inhibitor. Its effects on various enzymes involved in cAMP metabolism of function of cAMP were examined.

Full text

PDF
377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler J. Chemotaxis in bacteria. Science. 1966 Aug 12;153(3737):708–716. doi: 10.1126/science.153.3737.708. [DOI] [PubMed] [Google Scholar]
  2. Adler J., Templeton B. The effect of environmental conditions on the motility of Escherichia coli. J Gen Microbiol. 1967 Feb;46(2):175–184. doi: 10.1099/00221287-46-2-175. [DOI] [PubMed] [Google Scholar]
  3. Azuma H., Maruyama H. B. Biochemically active substances from Actinomycetes and other organisms. II. Effects of various compounds on motilometry. J Antibiot (Tokyo) 1974 Mar;27(3):185–191. doi: 10.7164/antibiotics.27.185. [DOI] [PubMed] [Google Scholar]
  4. Dalton C., Quinn J. B., Burghardt C. R., Sheppard H. Investigation of the mechanism of action of the lipolytic agent 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956). J Pharmacol Exp Ther. 1970 Jun;173(2):270–276. [PubMed] [Google Scholar]
  5. Dobrogosz W. J., Hamilton P. B. The role of cyclic AMP in chemotaxis in Escherichia coli. Biochem Biophys Res Commun. 1971 Jan 22;42(2):202–207. doi: 10.1016/0006-291x(71)90088-x. [DOI] [PubMed] [Google Scholar]
  6. Maruyama H. B., Azuma H. Biochemically active substances from Actinomycetes and other organisms. I. "Motilometry", a simple and quantitative assay method for motility inhibitors. J Antibiot (Tokyo) 1974 Mar;27(3):178–184. doi: 10.7164/antibiotics.27.178. [DOI] [PubMed] [Google Scholar]
  7. Miyamoto E., Kuo J. F., Greengard P. Cyclic nucleotide-dependent protein kinases. 3. Purification and properties of adenosine 3',5'-monophosphate-dependent protein kinase from bovine brain. J Biol Chem. 1969 Dec 10;244(23):6395–6402. [PubMed] [Google Scholar]
  8. Snow G. A. Mycobactins: iron-chelating growth factors from mycobacteria. Bacteriol Rev. 1970 Jun;34(2):99–125. doi: 10.1128/br.34.2.99-125.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. TSUKIURA H., OKANISHI M., OHMORI T., KOSHIYAMA H., MIYAKI T., KITAZIMA H., KAWAGUCHI H. DANOMYCIN, A NEW ANTIBIOTIC. J Antibiot (Tokyo) 1964 Mar;17:39–47. [PubMed] [Google Scholar]
  10. Trouet A. Immunisation de lapins par des lysosomes hépatiques de rats traités au Triton WR 1339. Arch Int Physiol Biochim. 1964 Sep;72(4):698–700. [PubMed] [Google Scholar]
  11. Yokota T., Gots J. S. Requirement of adenosine 3', 5'-cyclic phosphate for flagella formation in Escherichia coli and Salmonella typhimurium. J Bacteriol. 1970 Aug;103(2):513–516. doi: 10.1128/jb.103.2.513-516.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES